Aurinia Pharmaceuticals Inc.
AUPH
$8.18
$0.080.99%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -90.04% | 1,887.53% | 106.72% | 60.00% | -99.86% |
| Total Depreciation and Amortization | -0.63% | 1.03% | -0.08% | -2.06% | -5.95% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -86.35% | 118.77% | 332.40% | -111.51% | 90.73% |
| Change in Net Operating Assets | 286.53% | -308.48% | 153.72% | -155.38% | 239.75% |
| Cash from Operations | 76.84% | 7.49% | 185.19% | -229.95% | 207.80% |
| Capital Expenditure | -- | -- | -- | -- | -384.76% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 473.67% | 72.63% | -178.45% | 926.33% | 69.92% |
| Cash from Investing | 471.01% | 72.63% | -178.45% | 886.85% | 68.24% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -2.43% | 8.22% | -16.02% | 57.54% | -87.91% |
| Issuance of Common Stock | 3,256.78% | -78.23% | 3,771.43% | -99.14% | 182.17% |
| Repurchase of Common Stock | -- | 100.00% | 50.13% | -439.75% | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -746.66% | 67.10% | 45.03% | -169.88% | -139.15% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1,139.38% | 112.03% | -299.26% | 528.89% | 107.02% |